Pace Ventures — 2025 Investments
2 investments dated 2025 · listed companies and verified rows first · show all
Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE
Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel
PartnerMarius Swart· solo GP
Co-investorsFrontline VenturesY CombinatorSARAS CAPITALSpringboard Health Angels
ChemFinity develops advanced chemical separation technologies for recovering critical minerals and other resources.
CleantechDeep TechNew MaterialsBrooklyn, US
Adam Uliana(Executive Officer, Director)Ever Velasquez(Director)
PartnerMarius Swart· solo GP
Co-investorsAt One VenturesCreative Destruction Lab (CDL)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.